AstraZeneca PLC Ordinary Shares (AZN)

CapEx to Revenue

4.95%

Quarterly · Period ending:

AZN logo

AZN CapEx to Revenue

Latest reported4.95%
AZN Quarterly CapEx/Revenue (0.00% → 4.95%)
High-resolution chart · PNG

AZN capex to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares CapEx to Revenue — Quarterly
Period endingCapEx to Revenue
4.9548%
10.0602%
8.3016%
11.362%
12.9553%
6.9417%
6.5694%
9.7245%
5.1469%
12.7883%
7.722%
7.958%
4.1826%
13.2825%
4.7175%
10.7498%
5.2094%
3.2586%
5.9199%
6.8236%
4.3467%
5.5692%
6.7167%
10.4536%
15.3825%
5.8056%
5.4754%
5.1222%
16.9619%
12.5764%
5.73%
4.6772%
6.538%
6.3849%
9.4124%
5.5317%
6.4777%
7.074%
11.6061%
6.5031%
17.8654%
5.0041%
8.3607%
8.9823%
10.2109%
17.7481%
7.0178%
6.3436%
17.6635%
11.3466%
11.4845%
7.584%
6.1617%
6.4839%
7.7451%
53.457%
4.2192%
2.7487%
4.3669%
2.9709%
4.7924%
3.2682%
3.1682%
3.6085%
11.8%
13.5145%
21.8781%
5.561%
3.2672%
3.6878%
6.0173%
3.8714%
3.8587%
38.2702%
5.765%
6.3357%
4.8123%
5.814%
3.9838%
5.3714%
6.2642%
4.6764%
1.384%
4.7331%
3.5388%
4.0397%
16.1752%
10.5033%
12.6324%
0.1971%
0%
0%
0%
0%
0%
0%
8.1206%
6.4465%
0%
9.1646%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.